Curator: Aviva Lev-Ari, PhD, RN
Sunitinib brings Adult acute lymphoblastic leukemia (ALL) to Remission – RNA Sequencing – FLT3 Receptor Blockade
Advertisements
REMISSION to Adult Acute Lymphoblastic Leukemia (ALL): Pfizer’s Sutent blocks FLT3 Gene Receptors
July 10, 2012 by 2012pharmaceutical
2 Responses
Leave a Reply
Advertisements
-
Recent Posts
- Selection Process for Chief Innovation and Entrepreneurship Officer (CIEO) @Berkeley: Ecosystem Evangelist, Professor Richard Lyons, Berkeley’s ex-Dean of the Haas School of Business July 22, 2019
- Multiple Barriers Identified Which May Hamper Use of Artificial Intelligence in the Clinical Setting July 21, 2019
- Single-cell RNA-seq helps in finding intra-tumoral heterogeneity in pancreatic cancer July 21, 2019
- 15th Annual Personalized Medicine Conference at Harvard Medical School – THE PARADIGM EVOLVES, November 13 – 14, 2019 • Harvard Medical School, Boston, MA July 19, 2019
- Charles River Laboratories – World Congress, Delivering Therapies to the Clinic Faster, September 23 – 24, 2019, Cambridge, MA July 19, 2019
- 2019 Warren Alpert Foundation Award goes to Four Scientists for Seminal Discoveries in OptoGenetics – Illuminating the Human Brain July 18, 2019
- At Technical University of Munich (TUM) Successful Genetical modification of a patient’s own immune cells, T cell receptors, using CRISPR-Cas9 gene editing tool. The engineered T cells are very similar to the physiological immune cells. July 17, 2019
- scPopCorn: A New Computational Method for Subpopulation Detection and their Comparative Analysis Across Single-Cell Experiments July 16, 2019
- Engineered Bacteria used as Trojan Horse for Cancer Immunotherapy July 13, 2019
- @BroadInstitute a shift from Permanently editing DNA to Temporarily revising RNA – An approach with promise for addressing the risk of developing Alzheimer’s by deactivating APOE4 – RESCUE: RNA Editing for Specific C to U Exchange, the platform builds on REPAIR: RNA Editing for Programmable A to I July 12, 2019
Archives
Categories
Meta
-
2012pharmaceutical
-
Aashir Awan, Phd
-
Alan F. Kaul, PharmD., MS, MBA, FCCP
-
alexcrystal6
-
amnondanzig1724
-
anamikasarkar
-
apreconasia
-
aviralvatsa
-
David Orchard-Webb, PhD
-
danutdaagmailcom
-
Demet Sag, Ph.D., CRA, GCP
-
Dror Nir
-
evelinacohn
-
Gail S Thornton
-
Irina Robu
-
jdpmd
-
kellyperlman
-
Ed Kislauskis
-
larryhbern
-
lmulligan13gmailcom
-
marzankhan
-
megbaker58
-
pkandala
-
Rosalind Codrington, PhD
-
ritusaxena
-
Rick Mandahl
-
sjwilliamspa
-
stuartlpbi
-
Dr. Sudipta Saha
-
tildabarliya
-
zraviv06
-
zs22
-
Advertisements
[…] REMISSION to Adult Acute Lymphoblastic Leukemia (ALL): Pfizer’s Sutent blocks FLT3 Gene Receptors […]
[…] https://pharmaceuticalintelligence.com/2012/07/10/remission-to-adult-acute-lymphoblastic-leukemia-all… […]